Mateo Alajarin graduated in chemistry at the Universidad de Murcia, where he also received his PhD. After postdoctoral studies with Prof. Alan R. Katritzky at the University of Florida (USA) he returned to the Universidad de Murcia where he is currently Full Professor at its Department of Organic Chemistry. His research interests include ketenimines and related heterocumulenes, supramolecular chemistry, organophosphorus reagents, tandem processes promoted by H shifts, and other pericyclic and pseudopericyclic reactions.
Giovanna Bosica graduated cum laude from the University of Camerino, Italy, in 1993 with a Laurea degree, equivalent to M.Sc.(Hons), in Chemistry and obtained her Ph.D. degree in Chemical Sciences, in the field of organic synthesis, in 1997 from the same institution. In 1995 during her Ph.D. she spent a six months research period at the University of Nijmegen, the Netherlands, as an Erasmus Fellow.
In 1999 she was appointed Assistant Professor of Organic Chemistry at the University of Camerino.
In October 2008 she moved to the University of Malta where she was appointed Associate Professor of Organic Chemistry in the Department of Chemistry and subsequently obtained the promotion to full Professor in March 2014. She lectures for different courses in the field of organic chemistry/synthesis and natural products.
She is member of the Royal Chemical Society (MRSC) since 2011 and of the American Chemical Society (ACS) since 2015. In March 2016 she has joined the European COST Association, participating at the COST Action CA15106, C-H Activation in Organic Synthesis (CHAOS), as a MC member from Malta [CA15106 MT].
Dr. Mukund Chorghade is President and Chief Scientific Officer, THINQ Pharma / MVRC Research/ Chicago Discovery Solutions. He has had Adjunct Research Professor / Visiting Fellow / Scientists appointments at Harvard, MIT, Princeton, Cambridge, Caltech, Univ. of Chicago, Rutgers, Strathclyde and others. He provides synthetic chemistry and pharmaceutical development expertise to academic laboratories, pharmaceutical and biopharmaceutical companies. His research interests are in Traditional Medicine derived New Chemical Entities and the discovery of “chemosynthetic livers” that find utility in drug metabolism, valorization of biomass and environmental remediation.
Dr. Chorghade earned B. Sc. M. Sc. degrees from the University of Poona, and a Ph. D. at Georgetown University. He completed postdoctoral appointments at the University of Virginia and Harvard, visiting scientist appointments at University of British Columbia, College de France / Universite’ Louis Pasteur, Cambridge and Caltech and directed research groups at Dow Chemicals, Abbott Laboratories, CytoMed and Genzyme. He received three “Scientist of the Year Awards”, and is on the Scientific Advisory Board of several corporations / foundations. He is a Fellow of the ACS, AAAS, AIC and RSC, the Maharashtra, Andhra Pradesh and Telengana Academy of Sciences and has been a featured speaker in national and international symposia
Our research interests are primarily in the development of novel organic synthetic methods, especially ones that are “greener” than traditionally and synthesis of compounds with interesting properties. Particular current research projects involve use of zeolites and solid-supported reagents and catalysts to gain selectivity in organic reactions; lithiation reactions which we have used to devise novel heterocyclic ring syntheses and to introduce selectivity into aromatic and heterocyclic substitution reactions; heterocyclic chemistry; polymeric materials and design and synthesis of novel compounds with interesting chemiluminescent or other photoactive properties. The current research focuses on the chemistry of tear ferning which is a valuable tool in the detection of dryness of eye. We are investigating the dryness of the eye through evaluation of tear osmolarity using the TearLab system and various other techniques. Also, we are investigating the ocular tear film in diabetic and smoker subjects to test the correlation between dryness of the eye and diabetes disease and nicotine.
Carlos F. Marcos holds a Ph.D. in Organic Chemistry from the University of Santiago of Compostela, where he specialized in chemistry of heterocycles and total synthesis of natural products. He completed his training on the chemistry of the organometallic compounds at the University of Milan and at the Imperial College London, where he was awarded with a grant of the Human Capital and Mobility programme of the European Community.
In 1996 he joined the University of Extremadura, where he started a line of research on new sulfur heterocyclic materials, in collaboration with professors Charles Rees (Imperial College) and Tomás Torroba (UEx). From 2002, he leads a research group involved in the development of new synthetic methodologies. Throughout his career, he has supervised many research studies and has more than 50 publications indexed in frontline scientific journals. He has also made several stays as visiting professor in prestigious American and European research centres. From 2016, it holds a position as Full Professor at the University of Extremadura.
In recent years his research has focused in the chemistry of isocyanides, and especially their use to develop new tandem and multi-component processes. These synthetic strategies have proved to be a very advantageous approach to obtain organic materials with new properties, as well as compounds with biomedical interest.
I obtained my PhD from the University of Valencia (Spain) focused on Supramolecular & Bioinorganic Chemistry, in which I worked in metalloenzymes mimetics and anion receptors. Upon completing my PhD in 2013, I performed several postdoctoral research positions in the University of Kansas (USA) and Institute Curie (France), in which I specialized in the development of drugs for non-canonical nucleic acids such as G-quadruplexes, triplexes or i-motifs. Then, I joined the Department of Chemistry at Imperial College London as Newton Fellow to develop new tools to target and visualize G-quadruplexes in cells. I continued my projects as IdEx Fellow in the European Institute of Chemistry and Biology in Bordeaux (France). Actually, I’ve started my team in the Institute of Molecular Science in the University of Valencia, where I’ve developed novel systems and methodologies to target non-canonical DNA structures and unravel their biological roles.
PhD University of British Columbia (Organic Synthesis)
Post Doctoral: Prof. David Dolphin, Prof. Chris Orvig (UBC, Chemistry); Prof Val Stella (U Kansas, Pharm Chem)
Fellow Royal Society of Chemistry
Fellow National Academy of Sciences, Sri Lanka
Chevalier dans l'Ordre des Palmes Académiques (Knight of the Order of Academic Palms (Awarded by the Government of France) 2012.
Former Head, Department of Chemistry, University of Peradeniya
Former Science Team Leader, Sri Lanka Institute of Nanotechnology (SLINTEC)
Former Associate Director Science & Strategic Relations (SLINTEC)
Vice Chancellor, SLINTEC ACADEMY
Professor, University of Peradeniya
Published 140 papers in peer reviewed journals
Inventor of 6 patents
Supervised 15 PhD and 10 MPhil students
H Index 29
Dr. Naddeo is associate professor at Department of Civil Engineering of the University of Salerno (Italy) where he drives research activities as Director of the Sanitary Environmental Engineering Division (SEED).
He is co-founding Chair of the conference series WaterEnergyNEXUS and is actively involved in a variety of scientific organizations, funding agencies, and European networks.
His research focuses on water/wastetater treatment, recovery of energy form waste, control of environmental odors and environmental impact assessment (EIA). He developed advanced biological processes for wastewater treatment and control of emerging contaminants, novel ultrasound-based technological processes for the treatment of environmental matrices (solid, liquid and gaseous) and biotechnologies for wastewater re-use with simultaneous energy production.
In addition to the topics above, Dr. Naddeo has published works on membrane bioreactors (MBRs), Advanced Oxidation Processes (AOPs), river water quality characterization, remediation of contaminated soil, management & treatment of the organic fraction of solid waste, strategic environmental assessment (SEA) & recently on the environmental technologies for the sustainable development of smart cities.
Educational Background: B.Sc. Chemistry (Industrial Option), 1st Class Honors, 1992, University of Ibadan, Nigeria. Ph.D. Organic Chemistry, 1998, Brown University, Providence Rhode Island
July 1998 – Nov. 2001: Postdoctoral Associate and Jane Coffin Childs Postdoctoral Fellow, Dept. of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut.
Nov. 2001 – Jan. 2004: Research Scientist II, Rib-X Pharmaceuticals, Inc.
Jan. 2004 – Aug. 2005: Senior Research Scientist, Rib-X Pharmaceuticals, Inc.
Aug. 2005 – April 2011: Assistant Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
Dec. 2007 – Nov. 2009: Blanchard Assistant Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
April 2011 – present: Associate Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
Dr. Ravindra K. Rawal is a Professor of Chemistry at Maharishi Markandeshwar (Deemed to be University), Mullana (Haryana). Professor & Head at ISF College of Pharmacy, Moga. Postdoctoral Associate with Distinguished Prof. C.K. Chu’s Drug Discovery group in the College of Pharmacy, University of Georgia, USA. Postdoctoral Research Fellow with Prof. Don J. Diamond in the virology division of Beckman Research Institute, City of Hope, USA.
Dr. Rajesh Kumar Singh was born in 1980. He received his B. Pharmacy (2003) and M. Pharmacy (2005) from UIPS, Panjab University, Chandigarh. He completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar.
Dr. Singh’s major area of research interests are synthetic medicinal chemistry, polymer-drug conjugates for targeted delivery, Antimalarial and CNS active therapeutic agents and green chemistry approaches for chemical synthesis of pharmaceutical molecules.
Dr. Singh has over 14 years of teaching experience, guided 18 PG and 01 Ph.D. students and currently guiding 02 PhD students. He has published more than 60 peer-reviewed scientific research papers in SCI indexed various Chemistry and Pharmacy Journals of impact factor 1.5 to 4.8 as the main or corresponding author.
Dr. Singh is Editorial Board Member of SCOPUS indexed 06 Int. Journals. He has received Publon Award 2016, 2017 and Publon “Excellent Peer Reviewer award” for outstanding reviewing more than 120 research papers of different International Journals of ACS, RSC, Springer, Elsevier, Dove, Informa and Bentham of Impact Factor varies from 1.0 to 8.5. He has also to his credit more than 50 National and International Conference Abstracts, 2 Books, 5 Best Paper Presentation Awards, 1 Travel grant to attend Int. Conf. and 5 Research Projects funded by various government funding agencies.
I am Principal Lecturer in Organic Medicinal Chemistry at the University of Central Lancashire (UCLan) and is group leader for the Organic Medicinal Research Group.
My main research focus is in the area of synthetic medicinal chemistry with much of the research focused towards the development of dyes and probes towards healthcare applications. I am also interested in designing new antimicrobials which is focused around small molecule design. Another area which interests me is the chemistry of ascorbic acid and utilising its amazing properties to generate new medicinally active compounds.